Inflammatory Diseases Completed Phase 1 Trials for Deucravacitinib (DB16650)

Also known as: Inflammatory Disease

IndicationStatusPhase
DBCOND0041144 (Inflammatory Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03044873Effect of BMS-986165 on the Pharmacokinetics of RosuvastatinBasic Science